Table 3.
Comparison of POC Trichomonas tests in women. Sensitivity estimates are relative to NAAT gold standard. Published comparisons are referenced.
| Test | Author | N | Prevalence (% positive) |
Reference standard |
Sensitivity | Specificity |
|---|---|---|---|---|---|---|
|
XenoStrip Tv™ |
Miller, et al (2003) |
60 | (33%) | Culture | 90% | 92.5% |
| Kurth, et al (2004) |
936 | 14.42% | Culture | 78.5% | 98.6% | |
| OSOM® TV | Huppert, et al(2005) |
449 | 23.4% | Wet mount and culture |
83.3% | 98.8% |
| Huppert, et al. (2007) |
330 | 18.5% | wet mount, culture, and NAAT (TMA) |
90% | 100% | |
| Campbell, et al. (2008) |
1,009 | 2% | Wet mount | 94.7% | 100% | |
| Affirm®VPIII | Briselden and Hiller (1994) |
176 | 7% by wet mount 9% by culture |
Wet mount and culture |
83% | 100% |
| DeMeo, et al. (1996) |
615 | 15.4% | Wet mount and culture |
90.5% | 98% | |
| Product literature |
852 | 13% | Wet mount | 91.8% | 98.1% | |
| Culture | 89.2% | 99.3% | ||||
| Brown, et al (2004) |
425 | 7% by Affirm VPIII 5% by wet mount |
Wet mount | Not stated | Not stated | |
| Lowe, et al. (2009) | 535 | 1.5% | Clinical diagnosis |
too small to assess |
too small to assess |